Agarwal, R., Green, J. B., Heerspink, H. J. L., Mann, J. F. E., McGill, J. B., Mottl, A., … Nangaku, M. (2026). Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCE. Clin J Am Soc Nephrol, 21(1), 72–82. https://doi.org/10.2215/CJN.0000000865

Agarwal, Rajiv, Jennifer B. Green, Hiddo J. L. Heerspink, Johannes F. E. Mann, Janet B. McGill, Amy Mottl, Takeshi Osonoi, et al. “Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCE.” Clin J Am Soc Nephrol 21, no. 1 (January 1, 2026): 72–82. https://doi.org/10.2215/CJN.0000000865.

Agarwal R, Green JB, Heerspink HJL, Mann JFE, McGill JB, Mottl A, et al. Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCE. Clin J Am Soc Nephrol. 2026 Jan 1;21(1):72–82.

Agarwal, Rajiv, et al. “Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCE.” Clin J Am Soc Nephrol, vol. 21, no. 1, Jan. 2026, pp. 72–82. Pubmed, doi:10.2215/CJN.0000000865.

Agarwal R, Green JB, Heerspink HJL, Mann JFE, McGill JB, Mottl A, Osonoi T, Pal A, Rossing P, Rosenstock J, Vaduganathan M, Li L, Li N, Scott C, Manjrekar P, Yamashita S, Nangaku M. Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCE. Clin J Am Soc Nephrol. 2026 Jan 1;21(1):72–82.